⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iii verrucous carcinoma of the larynx

Every month we try and update this database with for stage iii verrucous carcinoma of the larynx cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsNCT00006036
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 YearsCanadian Cancer Trials Group
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionNCT00002901
Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerNCT02177838
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerNCT00023959
Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
hydroxyurea
fluorouracil
bevacizumab
radiation thera...
filgrastim
laboratory biom...
18 Years - National Cancer Institute (NCI)
Germline Mutations in Patients With Head and Neck Cancer and a Family History of CancerNCT00482872
Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 YearsVanderbilt University Medical Center
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity CancerNCT00963326
Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI)
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionNCT00002901
Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center
Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionNCT00002901
Breast Cancer
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
docetaxel
18 Years - City of Hope Medical Center
Study of Blood and Tissue Samples From Patients With Larynx Cancer, Pharynx Cancer, or Oral Cavity CancerNCT00963326
Head and Neck C...
laboratory biom...
15 Years - National Cancer Institute (NCI)
Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryNCT00041171
Adult Solid Tum...
Breast Cancer
Head and Neck C...
Kidney and Urin...
Male Reproducti...
Thorax and Resp...
Hypericum perfo...
docetaxel
placebo
18 Years - 120 YearsAlliance for Clinical Trials in Oncology
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsNCT00089362
Male Breast Can...
Recurrent Adeno...
Recurrent Basal...
Recurrent Breas...
Recurrent Colon...
Recurrent Esthe...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Melan...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Gastr...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Melan...
Stage III Midli...
Stage III Mucoe...
Stage III Ovari...
Stage III Renal...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Melano...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
Untreated Metas...
alvespimycin hy...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerNCT00897793
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
venipuncture
radiation thera...
18 Years - Vanderbilt-Ingram Cancer Center
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00721513
Head and Neck C...
cetuximab
cisplatin
docetaxel
fluorouracil
computed tomogr...
positron emissi...
quality-of-life...
3-dimensional c...
intensity-modul...
18 Years - 120 YearsWake Forest University Health Sciences
Docetaxel in Treating Patients With Solid TumorsNCT00003565
Bladder Cancer
Breast Cancer
Head and Neck C...
Lung Cancer
Unspecified Adu...
docetaxel
18 Years - Alliance for Clinical Trials in Oncology
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryNCT00738868
Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI)
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyNCT01728480
Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute
Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerNCT02177838
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Tongue Cancer
cetuximab
cisplatin
external beam r...
laboratory biom...
18 Years - Rutgers, The State University of New Jersey
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyNCT02123511
Mucositis
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Lympho...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Lymph...
Stage IVA Mucoe...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Lymph...
Stage IVB Mucoe...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Lymph...
Stage IVC Mucoe...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
acetylcysteine
placebo
quality-of-life...
questionnaire a...
18 Years - Mayo Clinic
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyNCT00898430
Head and Neck C...
DNA Microarray ...
MALDI-TOF mass ...
DNA microarray ...
- Vanderbilt-Ingram Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckNCT00720304
Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryNCT00738868
Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI)
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerNCT01313390
Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerNCT00293462
Head and Neck C...
Mucositis Oral
Radiation Toxic...
Tongue Cancer
sargramostim
oral salt and s...
18 Years - University of California, San Francisco
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.NCT01469429
Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00049283
Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Germline Mutations in Patients With Head and Neck Cancer and a Family History of CancerNCT00482872
Head and Neck C...
gene expression...
mutation analys...
polymerase chai...
polymorphism an...
flow cytometry
laboratory biom...
18 Years - 120 YearsVanderbilt University Medical Center
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive TractNCT00765440
Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 YearsCentre Antoine Lacassagne
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsNCT00006036
Head and Neck C...
Lung Cancer
Ovarian Cancer
Unspecified Adu...
cisplatin
lurtotecan lipo...
18 Years - 120 YearsCanadian Cancer Trials Group
Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00721513
Head and Neck C...
cetuximab
cisplatin
docetaxel
fluorouracil
computed tomogr...
positron emissi...
quality-of-life...
3-dimensional c...
intensity-modul...
18 Years - 120 YearsWake Forest University Health Sciences
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck CancerNCT00049283
Metastatic Squa...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
Untreated Metas...
erlotinib hydro...
docetaxel
radiation thera...
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck CancerNCT01155609
Mucositis
Oral Complicati...
Oral Complicati...
Recurrent Adeno...
Recurrent Basal...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Basal ...
Stage II Lympho...
Stage II Lympho...
Stage II Mucoep...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Basal...
Stage III Lymph...
Stage III Lymph...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
quality-of-life...
management of t...
L-lysine
18 Years - University of Washington
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck CancerNCT00002476
Head and Neck C...
bleomycin sulfa...
fluorouracil
leucovorin calc...
methotrexate
vincristine sul...
low-LET cobalt-...
low-LET photon ...
radiation thera...
18 Years - National Cancer Institute (NCI)
Quality-Of-Life Assessment in Patients With Head and Neck Cancer Treated With Radiation TherapyNCT01210872
Head and Neck C...
questionnaire a...
quality-of-life...
standard follow...
18 Years - 70 YearsNational Cancer Institute (NCI)
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckNCT00906360
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Tongue Cancer
Untreated Metas...
sunitinib malat...
pharmacological...
3-dimensional c...
cetuximab
18 Years - National Cancer Institute (NCI)
GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerNCT00293462
Head and Neck C...
Mucositis Oral
Radiation Toxic...
Tongue Cancer
sargramostim
oral salt and s...
18 Years - University of California, San Francisco
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerNCT00068497
Anaplastic Thyr...
Insular Thyroid...
Metastatic Para...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Parat...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Stage III Folli...
Stage III Papil...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IIIB Non-...
Stage IV Lympho...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Esthe...
Stage IVA Folli...
Stage IVA Inver...
Stage IVA Lymph...
Stage IVA Midli...
Stage IVA Mucoe...
Stage IVA Papil...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Esthe...
Stage IVB Folli...
Stage IVB Inver...
Stage IVB Lymph...
Stage IVB Midli...
Stage IVB Mucoe...
Stage IVB Papil...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Esthe...
Stage IVC Folli...
Stage IVC Inver...
Stage IVC Lymph...
Stage IVC Midli...
Stage IVC Mucoe...
Stage IVC Papil...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Thryoid Gland N...
Thyroid Gland M...
Tongue Cancer
Untreated Metas...
gefitinib
- National Cancer Institute (NCI)
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyNCT01728480
Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
entolimod
intensity-modul...
cisplatin
pharmacological...
laboratory biom...
18 Years - Roswell Park Cancer Institute
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive TractNCT00765440
Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 YearsCentre Antoine Lacassagne
Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck CancerNCT00616590
Fatigue
Head and Neck C...
Psychosocial Ef...
Sleep Disorders
medical chart r...
questionnaire a...
fatigue assessm...
quality-of-life...
21 Years - Vanderbilt University
Collecting and Storing Tissue Samples From Patients With Head and Neck CancerNCT00898300
Head and Neck C...
biologic sample...
biopsy
18 Years - Radiation Therapy Oncology Group
Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck CancerNCT00017511
Head and Neck C...
Oral Complicati...
Radiation Toxic...
cevimeline hydr...
18 Years - Daiichi Sankyo
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerNCT01313390
Head and Neck C...
docetaxel
everolimus
laboratory biom...
pharmacological...
18 Years - University College, London
Family Quality of Life Among Families With a Member Who is a Cancer PatientNCT00544336
Breast Cancer
Colorectal Canc...
Head and Neck C...
Lung Cancer
Prostate Cancer
Solid Tumor
questionnaire a...
survey administ...
quality-of-life...
21 Years - Vanderbilt-Ingram Cancer Center
Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck CancerNCT00090337
Head and Neck C...
Pain
acupuncture the...
standard follow...
- Memorial Sloan Kettering Cancer Center
Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and NeckNCT01192815
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
erlotinib hydro...
intensity-modul...
pharmacogenomic...
gene expression...
3-dimensional c...
biopsy
pharmacological...
laboratory biom...
questionnaire a...
enzyme-linked i...
polymorphism an...
18 Years - 70 YearsCase Comprehensive Cancer Center
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryNCT00738868
Head and Neck C...
cetuximab
stereotactic bo...
18 Years - National Cancer Institute (NCI)
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckNCT00720304
Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.NCT01469429
Metastatic Squa...
Salivary Gland ...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage 0 Nasopha...
Stage 0 Orophar...
Stage 0 Paranas...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Saliva...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Oral ...
Stage IVA Squam...
Stage IVA Nasal...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Oral ...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Oral ...
Stage IVC Squam...
Paranasal Sinus...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
placebo
laboratory biom...
questionnaire a...
chemoprevention
chemoprevention
placebo
21 Years - Ohio State University Comprehensive Cancer Center
Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & DysphagiaNCT00503776
Dysphagia
Head and Neck C...
Mucositis
Xerostomia
exercise interv...
amifostine trih...
therapeutic die...
21 Years - Vanderbilt-Ingram Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckNCT00720304
Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck CancerNCT00956007
Head and Neck C...
cetuximab
intensity-modul...
18 Years - Radiation Therapy Oncology Group
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerNCT02048020
Human Papilloma...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IV Squamo...
Stage IV Verruc...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
paclitaxel
carboplatin
intensity-modul...
quality-of-life...
19 Years - Jonsson Comprehensive Cancer Center
Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and NeckNCT00720304
Head and Neck C...
docetaxel
erlotinib hydro...
fluorescence in...
polymerase chai...
immunoenzyme te...
immunohistochem...
laboratory biom...
pharmacological...
therapeutic con...
intensity-modul...
radiation thera...
18 Years - Case Comprehensive Cancer Center
Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck CancerNCT00090337
Head and Neck C...
Pain
acupuncture the...
standard follow...
- Memorial Sloan Kettering Cancer Center
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsNCT00089362
Male Breast Can...
Recurrent Adeno...
Recurrent Basal...
Recurrent Breas...
Recurrent Colon...
Recurrent Esthe...
Recurrent Gastr...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Melan...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Gastr...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Melan...
Stage III Midli...
Stage III Mucoe...
Stage III Ovari...
Stage III Renal...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Breast...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Gastri...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Melano...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Unspecified Adu...
Untreated Metas...
alvespimycin hy...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerNCT00068497
Anaplastic Thyr...
Insular Thyroid...
Metastatic Para...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Parat...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Thyro...
Recurrent Verru...
Stage III Folli...
Stage III Papil...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage IIIB Non-...
Stage IV Lympho...
Stage IV Non-sm...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Basal...
Stage IVA Esthe...
Stage IVA Folli...
Stage IVA Inver...
Stage IVA Lymph...
Stage IVA Midli...
Stage IVA Mucoe...
Stage IVA Papil...
Stage IVA Saliv...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Basal...
Stage IVB Esthe...
Stage IVB Folli...
Stage IVB Inver...
Stage IVB Lymph...
Stage IVB Midli...
Stage IVB Mucoe...
Stage IVB Papil...
Stage IVB Saliv...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Basal...
Stage IVC Esthe...
Stage IVC Folli...
Stage IVC Inver...
Stage IVC Lymph...
Stage IVC Midli...
Stage IVC Mucoe...
Stage IVC Papil...
Stage IVC Saliv...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Thryoid Gland N...
Thyroid Gland M...
Tongue Cancer
Untreated Metas...
gefitinib
- National Cancer Institute (NCI)
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck CancerNCT00006799
Anorexia
Cachexia
Head and Neck C...
Quality of Life
megestrol aceta...
quality-of-life...
18 Years - 120 YearsWake Forest University Health Sciences
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or ChemotherapyNCT01164566
Stage I Adenoid...
Stage I Mucoepi...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Mucoep...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Mucoe...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Mucoep...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
endoscopic proc...
questionnaire a...
18 Years - Wake Forest University Health Sciences
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and NeckNCT01473784
Recurrent Adeno...
Recurrent Mucoe...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage 0 Hypopha...
Stage 0 Larynge...
Stage 0 Lip and...
Stage I Adenoid...
Stage I Mucoepi...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage II Adenoi...
Stage II Mucoep...
Stage II Squamo...
Stage II Squamo...
Stage II Squamo...
Stage II Verruc...
Stage II Verruc...
Stage III Adeno...
Stage III Mucoe...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IVA Adeno...
Stage IVA Mucoe...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Adeno...
Stage IVB Mucoe...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Adeno...
Stage IVC Mucoe...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
transoral robot...
quality of life...
18 Years - Ohio State University Comprehensive Cancer Center
Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive TractNCT00765440
Head and Neck C...
Infection
Malnutrition
therapeutic nut...
placebo
18 Years - 75 YearsCentre Antoine Lacassagne
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerNCT00004065
Bladder Cancer
Breast Cancer
Colorectal Canc...
Gastric Cancer
Head and Neck C...
Kidney Cancer
Leukemia
Lung Cancer
Melanoma (Skin)
Ovarian Cancer
Prostate Cancer
Unspecified Adu...
tanespimycin
18 Years - Memorial Sloan Kettering Cancer Center
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckNCT01334177
Metastatic Squa...
Recurrent Metas...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Salivary Gland ...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Saliva...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Squam...
Stage IVC Verru...
Stage IVC Verru...
Tongue Cancer
TLR8 agonist VT...
cetuximab
laboratory biom...
pharmacogenomic...
18 Years - University of Washington
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsNCT00898638
Head and Neck C...
biologic sample...
medical chart r...
18 Years - Vanderbilt University Medical Center
Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck CancerNCT00820248
Head and Neck C...
panitumumab
cisplatin
3-dimensional c...
accelerated rad...
intensity-modul...
18 Years - Canadian Cancer Trials Group
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyNCT00898430
Head and Neck C...
DNA Microarray ...
MALDI-TOF mass ...
DNA microarray ...
- Vanderbilt-Ingram Cancer Center
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerNCT00492089
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation TherapyNCT01674374
Mucositis
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Squamo...
Stage IV Squamo...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Squam...
Stage IVA Verru...
Stage IVA Verru...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Squam...
Stage IVB Verru...
Stage IVB Verru...
Tongue Cancer
placebo
quality-of-life...
questionnaire a...
Vaccinium myrti...
18 Years - Roswell Park Cancer Institute
Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck CancerNCT00616590
Fatigue
Head and Neck C...
Psychosocial Ef...
Sleep Disorders
medical chart r...
questionnaire a...
fatigue assessm...
quality-of-life...
21 Years - Vanderbilt University
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerNCT00023959
Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
hydroxyurea
fluorouracil
bevacizumab
radiation thera...
filgrastim
laboratory biom...
18 Years - National Cancer Institute (NCI)
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerNCT00492089
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymom...
Adult Grade II ...
Adult Grade III...
Adult Malignant...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineocyto...
Malignant Neopl...
Meningeal Melan...
Radiation Toxic...
Recurrent Adeno...
Recurrent Adult...
Recurrent Basal...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage I Adenoid...
Stage I Basal C...
Stage I Esthesi...
Stage I Inverte...
Stage I Lymphoe...
Stage I Lymphoe...
Stage I Midline...
Stage I Mucoepi...
Stage I Salivar...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Squamou...
Stage I Verruco...
Stage I Verruco...
Stage III Adeno...
Stage III Basal...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
bevacizumab
placebo
magnetic resona...
quality-of-life...
18 Years - National Cancer Institute (NCI)
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerNCT00101348
Metastatic Squa...
Recurrent Adeno...
Recurrent Basal...
Recurrent Colon...
Recurrent Esthe...
Recurrent Inver...
Recurrent Lymph...
Recurrent Lymph...
Recurrent Metas...
Recurrent Midli...
Recurrent Mucoe...
Recurrent Non-s...
Recurrent Pancr...
Recurrent Recta...
Recurrent Saliv...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Squam...
Recurrent Verru...
Recurrent Verru...
Stage III Adeno...
Stage III Basal...
Stage III Colon...
Stage III Esthe...
Stage III Inver...
Stage III Lymph...
Stage III Lymph...
Stage III Midli...
Stage III Mucoe...
Stage III Pancr...
Stage III Recta...
Stage III Saliv...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Squam...
Stage III Verru...
Stage III Verru...
Stage IIIB Non-...
Stage IV Adenoi...
Stage IV Basal ...
Stage IV Colon ...
Stage IV Esthes...
Stage IV Invert...
Stage IV Lympho...
Stage IV Lympho...
Stage IV Midlin...
Stage IV Mucoep...
Stage IV Non-sm...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Renal ...
Stage IV Saliva...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Squamo...
Stage IV Verruc...
Stage IV Verruc...
Untreated Metas...
erlotinib hydro...
cetuximab
bevacizumab
laboratory biom...
18 Years - National Cancer Institute (NCI)
Side Effects of High-Dose Intensity-Modulated Radiation Therapy in Treating Patients With Advanced Head and Neck CancerNCT00415025
Head and Neck C...
Long-term Effec...
Oral Complicati...
Radiation Toxic...
adjuvant therap...
management of t...
quality-of-life...
intensity-modul...
18 Years - 120 YearsUniversity of Wisconsin, Madison
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsNCT00898638
Head and Neck C...
biologic sample...
medical chart r...
18 Years - Vanderbilt University Medical Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: